Form 4: Natera Co-Founder Exercises Stock Options, Sells Shares to Cover Tax Obligations

Natera's co-founder recently exercised stock options and sold a portion of shares to cover tax obligations, according to a recent SEC filing.'

Summary

• A Form 4 filing with the SEC details transactions made by Jonathan Sheena, a director and co-founder of Natera, Inc.
• Mr. Sheena exercised options to acquire 191 shares of common stock on January 20, 2025, and an additional 144 shares on January 21, 2025.
• On January 22, 2025, he sold 964 shares at a weighted average price of $164.9488 and 7 shares at a weighted average price of $171.9091.
• These sales were made to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).
• Following these transactions, Mr. Sheena directly owns 261,745 shares of Natera common stock.
• Additionally, 44,782 shares are held indirectly through each of the Caraluna 1 Trust and the Caraluna 2 Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are standard and expected. While the sale of shares could be seen as negative, the use of a 10b5-1 plan and the stated purpose of covering tax obligations mitigates any negative sentiment.

Positives

• The transactions were made pursuant to a pre-arranged 10b5-1 trading plan, which helps insiders avoid accusations of insider trading.
• The exercise of RSUs indicates that the co-founder is taking advantage of his earned equity, which can be seen as a positive sign of his continued involvement with the company.

Negatives

• The sale of shares, even to cover taxes, could be perceived negatively by the market, as it reduces the insider
• s direct stake in the company.'

Risks

• Market perception of insider selling could negatively impact the stock price, even if the sales are for legitimate reasons like tax obligations.
• Changes in tax laws or regulations could impact the timing or necessity of such sales in the future.

Future Outlook

The document does not provide explicit forward-looking statements or guidance.

Industry Context

This announcement is typical for executives at publicly traded companies who receive a significant portion of their compensation in equity. It reflects standard practices for managing personal finances and tax obligations related to equity compensation.

Comparison to Industry Standards

• This type of transaction is common among executives and directors in the biotech and tech industries, where equity compensation is a significant part of the pay structure.
• For example, executives at companies like Illumina (ILMN) and Exact Sciences (EXAS) also engage in similar transactions to manage their equity compensation and tax liabilities.
• These transactions are generally pre-planned under 10b5-1 plans to avoid insider trading concerns, which is a standard practice across the industry.

Stakeholder Impact

• Shareholders might react to the insider selling, but the impact is likely to be minimal given the stated reasons and the use of a 10b5-1 plan.

Key Dates

Keywords

Natera, NTRA, Insider Trading, Stock Options, SEC Form 4, 10b5-1 Plan, Restricted Stock Units, RSU, Tax Withholding, Beneficial Ownership, Securities Exchange Act of 1934, Jonathan Sheena